Finance

Lists
COR:NYSE
Cencora Inc
၃၃၀.၁၁ US$
+၁.၅၅%
(+၅.၀၅) 1D
၃၃၀.၁၁ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COR...
Open
၃၂၈.၀၇ US$
High
၃၃၁.၆၀ US$
Low
၃၂၇.၁၀ US$
Mkt. cap
ဋေ ၁.၄၆ ထ
Avg. vol.
၁.၂၆ သန်း
Volume
၃.၀၀
52-wk high
၃၇၇.၅၄ US$
52-wk low
၂၄၄.၈၂ US$
Beta
၀.၅၈
Shares outstanding
၁၉.၀၈ ကုဋေ
No. of employees
၅ သောင်း
Open
၃၂၈.၀၇ US$
High
၃၃၁.၆၀ US$
Low
၃၂၇.၁၀ US$
Mkt. cap
ဋေ ၁.၄၆ ထ
Avg. vol.
၁.၂၆ သန်း
Volume
၃.၀၀
52-wk high
၃၇၇.၅၄ US$
52-wk low
၂၄၄.၈၂ US$
Beta
၀.၅၈
Shares outstanding
၁၉.၀၈ ကုဋေ
No. of employees
၅ သောင်း
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
Healthcare Rout Slams Cencora Stock Despite Bullish Targets
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၂ နာရီ
Baird raises target for Cencora stock from USD 370 to USD 373
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees၄.၉ သောင်း
Founded၁၈၇၁
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 13 analysts giving stock ratings to COR in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for COR in the last 3 months.
Highest
Current ၃၃၀.၁၁ US$
၄၃၀.၀၀ US$ (+၃၀.၂၆%)
Average
၃၇၀.၇၅ US$ (+၁၂.၃၁%)
Lowest
၃၃၀.၀၀ US$ (-၀.၀၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
၃၈၈.၀၀ US$
+၁၇.၅%
10/07/2026
Ryan Halsted
RBC Capital
Hold
Maintained
၃၃၀.၀၀ US$
-၀%
10/06/2026
Glen Santangelo
Barclays
Buy
Reiterated
၃၅၀.၀၀ US$
+၆%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
၃၅၀.၀၀ US$
+၆%
08/13/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
၃၃၀.၀၀ US$
-၀%
08/12/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
၃၉၀.၀၀ US$
+၁၈.၁%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
၃၉၅.၀၀ US$
+၁၉.၇%
08/11/2026
Charles Rhyee
TD Cowen
Buy
Maintained
၄၀၀.၀၀ US$
+၂၁.၂%
08/09/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
၃၄၆.၀၀ US$
+၄.၈%
08/07/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
၃၇၀.၀၀ US$
+၁၂.၁%
08/06/2026
Kevin Caliendo
UBS
Buy
Maintained
၄၃၀.၀၀ US$
+၃၀.၃%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
၃၇၀.၀၀ US$
+၁၂.၁%
08/06/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
08/05/2026
Max Smock
William Blair
Hold
Maintained
-
-
05/22/2026
David Toung
Argus Research
Buy
Reiterated
၄၀၀.၀၀ US$
+၂၁.၂%
03/17/2026
Last report
၂၀၂၆ ဩ ၅
Fiscal period
Q3 2026
၄.၄၈ US$ / ၄.၃၅ US$
+၃.၀၄%beat
Revenue / Est. (USD)
ဋေ ၈.၄၈ ထ / ဋေ ၈.၄၁ ထ
+၀.၇၂%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၈.၃၇ ထ
ဋေ ၈.၅၉ ထ
ဋေ ၇.၈၄ ထ
ဋေ ၈.၄၈ ထ
Cost of goods sold
ဋေ ၈.၀၈ ထ
ဋေ ၈.၂၉ ထ
ဋေ ၇.၄၈ ထ
ဋေ ၈.၁၂ ထ
Cost of revenue
ဋေ ၈.၀၈ ထ
ဋေ ၈.၂၉ ထ
ဋေ ၇.၄၈ ထ
ဋေ ၈.၁၂ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၇၄.၈၉ ဋေ
၁၇၉.၅၃ ဋေ
၁၉၇.၇၆ ဋေ
၂၁၃.၂၅ ဋေ
Operating expense
၂၀၀.၃၆ ဋေ
၂၀၅.၆၁ ဋေ
၂၂၂.၇၄ ဋေ
၂၄၀.၂၈ ဋေ
Total operating expenses
ဋေ ၈.၂၈ ထ
ဋေ ၈.၄၉ ထ
ဋေ ၇.၇၀ ထ
ဋေ ၈.၃၆ ထ
Operating income
၉၄.၄၆ ကုဋေ
၁၀၀.၃၉ ဋေ
၁၃၄.၄၄ ဋေ
၁၁၉.၈၉ ဋေ
Other non operating income
-၄.၉၉ ကုဋေ
၁.၀၁ ကုဋေ
-၁.၇၃ သိန်း
၁.၆၉ ကုဋေ
EBT including unusual items
-၁၈.၇၀ ကုဋေ
၇၀.၈၆ ကုဋေ
၂၀၈.၈၆ ဋေ
၉၉.၆၄ ကုဋေ
EBT excluding unusual items
၇၉.၅၂ ကုဋေ
၉၄.၁၆ ကုဋေ
၁၂၀.၃၇ ဋေ
၁၀၇.၅၁ ဋေ
Income tax expense
၁၄.၆၀ ကုဋေ
၁၄.၂၅ ကုဋေ
၄၅.၉၀ ကုဋေ
၂၁.၉၇ ကုဋေ
Effective tax rate
-၇၈.၀၇%
၂၀.၁၁%
၂၁.၉၈%
၂၂.၀၅%
Other operating expenses
-၄.၀၀ သန်း
၃.၆၂ သိန်း
၅.၉၅ သိန်း
၈.၈၁ သိန်း
Net income
-၃၃.၉၇ ကုဋေ
၅၅.၉၆ ကုဋေ
၁၆၄.၁၃ ဋေ
၇၆.၃၅ ကုဋေ
Net profit margin
-၀.၄၁%
၀.၆၅%
၂.၀၉%
၀.၉၀%
Earnings per share
၃.၈၄
၄.၀၈
၄.၇၅
၄.၄၈
Interest and investment income
၃.၁၅ ကုဋေ
၂.၁၀ ကုဋေ
၁.၃၉ ကုဋေ
၁.၃၈ ကုဋေ
Interest expense
-၁၀.၉၄ ကုဋေ
-၉.၃၄ ကုဋေ
-၁၅.၄၃ ကုဋေ
-၁၅.၄၅ ကုဋေ
Net interest expenses
-၇.၇၈ ကုဋေ
-၇.၂၄ ကုဋေ
-၁၄.၀၅ ကုဋေ
-၁၄.၀၇ ကုဋေ
Depreciation and amortization charges
၁၃.၁၅ ကုဋေ
၁၃.၄၃ ကုဋေ
၁၃.၂၁ ကုဋေ
၁၅.၁၀ ကုဋေ
EBITDA
၁၂၀.၅၆ ဋေ
၁၂၆.၅၂ ဋေ
၁၆၀.၃၈ ဋေ
၁၄၇.၁၈ ဋေ
Gain or loss from assets sale
-
-၃.၅၈ ကုဋေ
-၂.၃၄ သိန်း
-၁.၆၀ ကုဋေ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ